机译:ASIMERTINIB用于次级T790M-突变阳性鳞状细胞癌转化AMATINIB失败后
Division of Lung/Head and Neck Oncology Department of Radiation Oncology Kyung Hee University;
Department of Pathology Kyung Hee University Medical Center Kyung Hee University School of;
Division of Pulmonary Allergy and Critical Care Medicine Department of Internal Medicine Kyung;
机译:ASIMERTINIB用于次级T790M-突变阳性鳞状细胞癌转化AMATINIB失败后
机译:表皮生长因子受体T790M突变阳性腺苷癌肺到小细胞癌和大细胞神经内分泌癌的转化:尸检案例报告
机译:在患有肺腺癌的患者中获得抗肺腺癌患者的抗鳞状细胞癌转化含有罕见的EGFR突变
机译:先前诊断为口腔扁平苔藓的鳞状细胞癌发展:从头还是转化?
机译:乳酸乳酸增加了Hraasg12V - 阳性口咽鳞状细胞癌中的免疫检查点难以表达
机译:在初始EGFR-TKI治疗失败后Osimertinib与T790M阳性非小细胞肺癌和多个中枢神经系统转移患者的ASIMERTINIB与AMATINIB
机译:在初始EGFR-TKI治疗失败后,Osimertinib与T790M阳性,非小细胞肺癌和多个中枢神经系统转移患者的ASIMERTINIB与AMATINIB